SAN DIEGO, May 18, 2020 (GLOBE NEWSWIRE) — Turning Point Therapeutics, Inc. (Nasdaq: TPTX), a precision oncology company developing next-generation […]
WATERTOWN, Mass., May 18, 2020 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing […]